Canada Pension Plan Investment Board’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.7M Sell
1,322,752
-141,806
-10% -$3.1M 0.02% 467
2025
Q4
$39.5M Buy
1,464,558
+141,806
+11% +$3.99M 0.03% 384
2025
Q3
$40M Hold
1,322,752
0.03% 382
2025
Q2
$35.3M Buy
+1,322,752
New +$35.6M 0.03% 372

Other funds holding CAI

Canada Pension Plan Investment Board's CAI Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Caris Life Sciences (CAI) stake by 9.7% in Q1 2026, selling an estimated $3.1M and leaving 1,322,752 shares worth $23.7M. The position accounts for 0.02% of the portfolio, ranked #467.

Canada Pension Plan Investment Board first reported a position in CAI in Q2 2025 and has held it in 4 quarters since. The position peaked at $40M in Q3 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Canada Pension Plan Investment Board held 1,322,752 shares of Caris Life Sciences worth $23.7M as of Q1 2026.
  • Canada Pension Plan Investment Board sold 141,806 Caris Life Sciences shares in Q1 2026, an estimated $3.1M.
  • Caris Life Sciences made up 0.02% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #467 holding.
  • Canada Pension Plan Investment Board first reported a position in Caris Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Canada Pension Plan Investment Board's Caris Life Sciences position peaked at $40M in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.